Evidence map›Paper›PMID 31919853›Full record

ReviewPhotochemistry and photobiology2020

Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer.

Scott C Hester, Maju Kuriakose, Christopher D Nguyen, Srivalleesha Mallidi

Open access · hybridAbstract readReview
In one paragraph

Review in Photochemistry and photobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Review
  3. Contrast Agents for Enhanced Bioimaging: A Comprehensive Review.Chembiochem : a European journal of chemical biology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Scott C HesterDepartment of Biomedical Engineering, Tufts University, Medford, MA.
Maju KuriakoseDepartment of Biomedical Engineering, Tufts University, Medford, MA.
Christopher D NguyenDepartment of Biomedical Engineering, Tufts University, Medford, MA.
Srivalleesha MallidiDepartment of Biomedical Engineering, Tufts University, Medford, MA.ORCID 0000-0003-1547-1764
Tufts University · US

Funding

Dual function theranostic constructs for photoacoustic guided surgery and photodynamic therapyR01CA231606 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HASAN, TAYYABA · 2019 to 2025
$3.1M
Raising the Therapeutic Index of Photodynamic Therapy with Targeted NanosyringesR41CA221420 · NCI · NANOHYBRIDS, INC. · PI COOK, JASON · 2017 to 2017
$300k
Enhancing Clinical Therapy for wet Age-related Macular Degeneration (wetAMD)R41EY028839 · NEI · NANOHYBRIDS, INC. · PI COOK, JASON · 2018 to 2018
$298k
NCI NIH HHS R01 CA231606NCI NIH HHS R41 CA221420NEI NIH HHS R41 EY028839NIH HHS EY028839NIH HHS R01CA231606NIH HHS R41CA221420
6 · The paper itself

Abstract

Photodynamic therapy (PDT) is a phototoxic treatment with high spatial and temporal control and has shown tremendous promise in the management of cancer due to its high efficacy and minimal side effects. PDT efficacy is dictated by a complex relationship between dosimetry parameters such as the concentration of the photosensitizer at the tumor site, its spatial localization (intracellular or extracellular), light dose and distribution, oxygen distribution and concentration, and the heterogeneity of the inter- and intratumoral microenvironment. Studying and characterizing these parameters, along with monitoring tumor heterogeneity pre- and post-PDT, provides essential data for predicting therapeutic response and the design of subsequent therapies. In this review, we elucidate the role of ultrasound (US) and photoacoustic imaging in improving PDT-mediated outcomes in cancer-from tracking photosensitizer uptake and vascular destruction, to measuring oxygenation dynamics and the overall evaluation of tumor responses. We also present recent advances in multifunctional theranostic nanomaterials that can improve either US or photoacoustic imaging contrast, as well as deliver photosensitizers specifically to tumors. Given the wide availability, low-cost, portability and nonionizing nature of US and photoacoustic imaging, together with their capabilities of providing multiparametric morphological and functional information, these technologies are thusly inimitable when deployed in conjunction with PDT.

Indexed as

PhotochemotherapyHumansNeoplasmsPhotoacoustic TechniquesPhotosensitizing AgentsUltrasonographyPhotosensitizing Agents

Identifiers

PMID31919853
PMCPMC7187279
OpenAlexW2999777566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.